Tekla Life Sciences Investors logo

HQL

Tekla Life Sciences Investors

$15.91

Earnings Summary

Revenue
$2.18Mn

Highlights

Revenue:

Tekla Life Sciences Investors’s revenue jumped 93.47% since last year same period to $2.18Mn in the Q1 2020. On a quarterly growth basis, Tekla Life Sciences Investors has generated 65.87% jump in its revenue since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Tekla Life Sciences Investors post its latest quarter earnings

EPS Estimate Current Quarter
0
EPS Estimate Current Year
0

Highlights

EPS Estimate Current Quarter:

Tekla Life Sciences Investors’s earning per share (EPS) estimates for the current quarter stand at 0 - a NaN% jump from last quarter’s estimates.

EPS Estimate Current Year:

Tekla Life Sciences Investors’s earning per share (EPS) estimates for the current year stand at 0.

Key Ratios

Key ratios of the Tekla Life Sciences Investors post its Q1 2022 earnings

Return on Assets (ROA)
-0.01
Return on Equity (ROE)
-0.09
Dividend Per Share (DPS)
1.65

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Tekla Life Sciences Investors’s return on assets (ROA) stands at -0.01.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Tekla Life Sciences Investors’s return on equity (ROE) stands at -0.09.

Dividend Per Share (DPS):

Tekla Life Sciences Investors declared 1.65 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2020-03-31
0
1.94
+Inf%

Company Information

Tekla Life Sciences Investors is a closed-end fund that invests in public and private companies in the life sciences industry. Tekla Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund.

Organisation
Tekla Life Sciences Investors
Headquarters
Boston, Massachusetts, US
Industry
Miscellaneous